Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Azelastine hydrochloride |
EINECS | 200-306-6 |
CAS No. | 79307-93-0 | Density | 1.25 g/cm3 |
PSA | 38.13000 | LogP | 5.03740 |
Solubility | 13 g/L at 20 °C (insoluble in ethanol, ether) | Melting Point |
225-229 °C |
Formula | C22H24ClN3O.HCl | Boiling Point | 533.9 °C at 760 mmHg |
Molecular Weight | 418.366 | Flash Point | 276.7 °C |
Transport Information | N/A | Appearance | white crystalline powder |
Safety | Risk Codes | 22 | |
Molecular Structure | Hazard Symbols | Xn | |
Synonyms |
1(2H)-Phthalazinone,4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-,monohydrochloride (9CI);A 5610;Allergodil;Astelin;Astepro;Azeptin;E 0659;Optivar;Rhinolast;W 2979M; |
Article Data | 4 |
Conditions | Yield |
---|---|
With C17H24N5Ru(1+)*F6P(1-); potassium acetate; potassium carbonate In 1-methyl-pyrrolidin-2-one at 35℃; for 72h; Inert atmosphere; Glovebox; | 90% |
Conditions | Yield |
---|---|
With water; iodine; sodium hydrogencarbonate In tetrahydrofuran at 20℃; for 4h; chemoselective reaction; | A 37% B 6% |
azelastine hydrochloride
azelastine
Conditions | Yield |
---|---|
With sodium hydroxide In water pH=10; Inert atmosphere; |
azelastine hydrochloride
2-(1-benzylazepan-4-yl)-4-(4-chlorobenzyl)phthalazin-1(2H)-one
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1.1: sodium hydroxide / water / pH 10 / Inert atmosphere 2.1: tri(4-tolyl)aminium hexafluorophosphate; 1,4-diaza-bicyclo[2.2.2]octane / acetonitrile / -5 °C / Inert atmosphere 2.2: 0 °C / Inert atmosphere View Scheme |
Product Name: Azelastine hydrochloride (CAS NO: 79307-93-0)
IUPAC Name: 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-onehydrochloride
Molecular formula: C22H25Cl2N3O
Formula weight: 418.36
Melting point: 225-229°C
Flash Point: 276.7 °C
Enthalpy of Vaporization: 81 kJ/mol
Boiling Point: 533.9 °C at 760 mmHg
Vapour Pressure: 1.77E-11 mmHg at 25°C
Chemical synonyms: a5610 ; azeptin;e-0659 ; w-2979m ; 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-phthalazin-1-one hydrochloride ; 4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone Hydrochloride
1. | orl-rat LD50:580 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),5231. | ||
2. | ivn-rat LD50:24,600 µg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),5231. | ||
3. | orl-mus LD50:143 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),5231. | ||
4. | ivn-mus LD50:25,400 µg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),5231. | ||
5. | orl-dog LD50:107 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),5235. |
Poison by ingestion and intravenous routes. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and HCl.
Side effects of azelastine nasal spray vary somewhat depending on the condition being treated. The most common side effects include bitter taste, headache, rhinitis, nose bleed, and somnolence. Adults being treated for vasomotor rhinitis may also experience dysesthesia and sinusitis. Additional side effects experienced by adults being treated for seasonal allergies include nasal burning, pharyngitis, dry mouth, paroxysmal sneezing, nausea, fatigue, dizziness, and weight gain. Additional side effect can include a slight mind alertness.